The Crisis in Antibiotic Research and Development
At a time when existing antibiotics are becoming ineffective, pharmaceutical companies are not investing enough in research and development for new antibiotics. Is the world staring at a serious health emergency in the near future? Director of the Global Antimicrobial Resistance Research and Development Hub Secretariat, Dr Lesley Ogilvie, spoke at a webinar hosted by the Centre for Science and Environment on what is needed to stimulate the antibiotic research and development ecosystem for sustainable and equitable antibiotic access.
The list of presenters and speakers was as follows:
➜ Rajeshwari Sinha, Centre for Science and Environment
➜ Sunita Narain, Centre for Science and Environment and Global Leaders Group on Antimicrobial Resistance
➜ James Anderson, International Federation of Pharmaceutical Manufacturers and Associations
➜ Richard Lawson, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator
➜ Lesley Ogilvie, Global Antimicrobial Resistance Research and Development Hub
➜ Amit Khurana, Centre for Science and Environment
➜ Rajeshwari Sinha, Centre for Science and Environment
➜ Gauri Arora, Centre for Science and Environment
The webinar page can be found here.
